| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0378 |
Hospital observation service, per hour |
1,232 |
1,090 |
$597K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,862 |
4,347 |
$416K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,044 |
1,871 |
$145K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
72 |
71 |
$130K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
683 |
614 |
$112K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,469 |
2,905 |
$91K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
204 |
130 |
$25K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
100 |
94 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
1,598 |
1,478 |
$6K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
217 |
206 |
$6K |
| 93793 |
|
818 |
576 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,909 |
1,423 |
$5K |
| 80053 |
Comprehensive metabolic panel |
6,788 |
5,285 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,443 |
1,174 |
$4K |
| 97597 |
|
120 |
73 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,419 |
5,940 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
913 |
823 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,239 |
1,146 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
391 |
373 |
$1K |
| 84484 |
|
2,705 |
1,980 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
78 |
75 |
$916.39 |
| 71045 |
Radiologic examination, chest; single view |
2,031 |
1,849 |
$834.78 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
201 |
193 |
$788.73 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
160 |
143 |
$702.19 |
| 81001 |
|
1,759 |
1,619 |
$450.91 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
121 |
114 |
$394.66 |
| 83735 |
|
3,987 |
3,217 |
$390.83 |
| 83690 |
|
1,738 |
1,573 |
$315.43 |
| 85610 |
|
3,552 |
2,520 |
$293.30 |
| 82150 |
|
586 |
531 |
$292.68 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
152 |
135 |
$282.28 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
656 |
586 |
$244.30 |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,174 |
1,142 |
$209.07 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
579 |
551 |
$197.22 |
| A6196 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing |
980 |
524 |
$134.41 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
465 |
231 |
$129.72 |
| 81003 |
|
807 |
752 |
$112.80 |
| 84443 |
Thyroid stimulating hormone (TSH) |
293 |
278 |
$105.33 |
| 84703 |
|
718 |
628 |
$98.47 |
| 80061 |
Lipid panel |
232 |
222 |
$91.90 |
| 85730 |
|
394 |
363 |
$69.88 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,977 |
1,537 |
$56.39 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$42.65 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
999 |
740 |
$42.27 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,173 |
884 |
$39.23 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
182 |
174 |
$32.39 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
433 |
251 |
$19.59 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
264 |
183 |
$17.80 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
301 |
235 |
$17.28 |
| 85027 |
|
53 |
38 |
$14.83 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,735 |
1,346 |
$13.92 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
628 |
353 |
$13.08 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
170 |
70 |
$12.59 |
| 83605 |
|
58 |
50 |
$11.01 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
421 |
376 |
$6.16 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
166 |
150 |
$3.75 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
109 |
76 |
$3.24 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
71 |
37 |
$0.23 |
| J2704 |
Injection, propofol, 10 mg |
483 |
414 |
$0.15 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
20 |
14 |
$0.00 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
24 |
24 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
48 |
37 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
43 |
25 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
15 |
12 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
26 |
26 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
42 |
36 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
40 |
29 |
$0.00 |
| 87040 |
|
27 |
25 |
$0.00 |
| 86850 |
|
14 |
12 |
$0.00 |
| 83880 |
|
12 |
12 |
$0.00 |
| 86901 |
|
14 |
12 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
575 |
430 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,053 |
765 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
53 |
51 |
$0.00 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
25 |
24 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
54 |
52 |
$0.00 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$0.00 |
| 86900 |
|
14 |
12 |
$0.00 |
| J7645 |
Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
24 |
15 |
$0.00 |